Five Prime Therapeutics, Inc. Operating Lease Cost
Five Prime Therapeutics, Inc. reported Operating Lease Cost of $6.61 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2021-03-22
- Five Prime Therapeutics, Inc. operating lease, cost for the quarter ending 2020-12-31 was $1.71M, a 11.30% increase year-over-year.
- Five Prime Therapeutics, Inc. operating lease, cost for the quarter ending 2020-09-30 was $1.50M, a 0.00% change year-over-year.
- Five Prime Therapeutics, Inc. operating lease, cost for the quarter ending 2020-06-30 was $1.90M, a 26.67% increase year-over-year.
- Five Prime Therapeutics, Inc. operating lease, cost for the quarter ending 2020-03-31 was $1.50M, a 0.00% change year-over-year.
- Five Prime Therapeutics, Inc. operating lease, cost for fiscal 2020 was $6.61M, a 7.72% increase from fiscal 2019.
- Five Prime Therapeutics, Inc. operating lease, cost for fiscal 2019 was $6.14M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $3.21M derived: sum of 2 quarters · filed 2021-03-22 | $5.11M derived: sum of 3 quarters · filed 2021-03-22 | $6.61M 10-K · filed 2021-03-22 | |
| 2020-09-30 | $1.50M 10-Q · filed 2020-11-03 | $3.40M derived: sum of 2 quarters · filed 2020-11-03 | $4.90M 10-Q · filed 2020-11-03 | $6.44M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-06-30 | $1.90M 10-Q · filed 2020-08-06 | $3.40M 10-Q · filed 2020-08-06 | $4.94M derived: sum of 3 quarters · filed 2021-03-22 | $6.44M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-03-31 | $1.50M 10-Q · filed 2020-05-07 | $3.04M derived: sum of 2 quarters · filed 2021-03-22 | $4.54M derived: sum of 3 quarters · filed 2021-03-22 | $6.04M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2019-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $3.04M derived: sum of 2 quarters · filed 2021-03-22 | $4.54M derived: sum of 3 quarters · filed 2021-03-22 | $6.14M 10-K · filed 2021-03-22 | $6.10M 10-K · filed 2020-02-27 |
| 2019-09-30 | $1.50M 10-Q · filed 2020-11-03 | $3.00M derived: sum of 2 quarters · filed 2020-11-03 | $4.60M 10-Q · filed 2020-11-03 | ||
| 2019-06-30 | $1.50M 10-Q · filed 2020-08-06 | $3.10M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $1.50M 10-Q · filed 2020-05-07 |